Rene Russo
CEO at Xilio Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Xilio Therapeutics Inc., 3 years.
Xilio Therapeutics Inc.
Director · PRESIDENT AND CEO
Chief executive roles
Xilio Therapeutics Inc.
· CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 1, 2026 | Xilio Therapeutics Inc. | Option exercise | +44,250 | — | — |
| Jun 16, 2025 | Xilio Therapeutics Inc. | Open-market purchase | +36,289 | $0.68 | $24,677 |
| Jan 1, 2025 | Xilio Therapeutics Inc. | Option exercise | +44,250 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.